The ICON team are at AAPS NBC. Stop by booth \#404 to discuss how our comprehensive bioanalytical and early clinical manufacturing solutions can support your research and development goals. https://www.aaps.org/nbc
-
ICON plc set to join Russell 3000® Index
ICON plc is set to join the broad-market Russell 3000® Index at the conclusion of the 2023 Russell indexes annual reconstitution.
-
ICON releases its 2022 ICON Cares ESG report
ICON announced the release of its ICON Cares 2022 Environmental, Social and Governance (ESG) Report.
-
ICON reports first quarter 2023 results
Revenue for the first quarter was $1,978.6 million. This represents an increase of 4.0% on prior year revenue or 5.3% on a constant currency organic basis.
-
LEO Pharma and ICON enter a strategic partnership to propel clinical trial execution within medical dermatology
Leo Pharma Group and ICON plc today announced a strategic partnership to improve dermatology patients' lives through innovative clinical trials.
-
ICON plc to present at upcoming investor conferences
Mr. Brendan Brennan, CFO of ICON plc, will present at the 2023 Citi Healthcare Conference and Dr. Steve Cutler, CEO of ICON plc, will present at the Barclays Global Healthcare Conference.
-
ICON reports fourth quarter and full year 2022 results
Full year net business wins of $9,450 million; a net book to bill of 1.22.
-
ICON plc schedules fourth quarter 2022 earnings conference call
ICON plc announced that it will release its financial results for the fourth quarter 2022 after the market closes on Wednesday, February 22, 2023.
-
ICON issues financial guidance for full year 2023
ICON plc announced today its financial guidance for the year ending December 31, 2023.
-
ICON plc to present at the 41st Annual J.P. Morgan healthcare conference
ICON plc announced today that Dr. Steve Cutler, CEO of ICON plc, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 5:15pm PST/ 8.15pm EST.
-
ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others
ICON finishes the second half of 2022 with an impressive line-up of awards that commend its healthcare intelligence work and status as an employer of choice.
